大葉大學圖書館 |

Pan-cancer integrative molecular portrait towards a new paradigm in precision medicine[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.027
書名/作者:	Pan-cancer integrative molecular portrait towards a new paradigm in precision medicine/ edited by Christophe Le Tourneau, Maud Kamal.
其他作者:	Le Tourneau, Christophe.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	x, 144 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Clinical trials.
標題:	Cancer - Molecular aspects.
標題:	Cancer - Genetic aspects.
標題:	Medicine& Public Health.
標題:	Oncology.
標題:	Pathology.
標題:	Cancer Research.
標題:	Molecular Medicine.
ISBN:	9783319221892
ISBN:	9783319221885
內容註:	Introduction: Rationale for Precision Medicine Clinical Trials -- The Key Role of Pathology in the Context of Precision Medicine Trials -- Basis for Molecular Genetics in Cancer -- Microarrays Based Molecular Profiling to Identify Genomic Alterations -- High Throughput Technologies: DNA and RNA Sequencing Strategies and Potential -- Bioinformatics for Precision Medicine in Oncology -- Assessment of Biomarkers' Predictive Value of Efficacy -- Designs for Evaluating Precision Medicine Trials -- Conclusions and Perspectives: Challenges for the Clinical Implementation of Precision Medicine Trials.
摘要、提要註:	This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the world's foremost cancer research institutions.
電子資源:	http://dx.doi.org/10.1007/978-3-319-22189-2

Pan-cancer integrative molecular portrait towards a new paradigm in precision medicine[electronic resource] /
Pan-cancer integrative molecular portrait towards a new paradigm in precision medicine[electronic resource] /edited by Christophe Le Tourneau, Maud Kamal. - Cham :Springer International Publishing :2015. - x, 144 p. :ill. (some col.), digital ;24 cm.

Introduction: Rationale for Precision Medicine Clinical Trials -- The Key Role of Pathology in the Context of Precision Medicine Trials -- Basis for Molecular Genetics in Cancer -- Microarrays Based Molecular Profiling to Identify Genomic Alterations -- High Throughput Technologies: DNA and RNA Sequencing Strategies and Potential -- Bioinformatics for Precision Medicine in Oncology -- Assessment of Biomarkers' Predictive Value of Efficacy -- Designs for Evaluating Precision Medicine Trials -- Conclusions and Perspectives: Challenges for the Clinical Implementation of Precision Medicine Trials.

This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the world's foremost cancer research institutions.

ISBN: 9783319221892

Standard No.: 10.1007/978-3-319-22189-2doiSubjects--Topical Terms:

339385
Clinical trials.

LC Class. No.: R853.C55

Dewey Class. No.: 616.027

Pan-cancer integrative molecular portrait towards a new paradigm in precision medicine[electronic resource] /
LDR:02369nam a2200313 a 4500 001 443568
003 DE-He213
005 20160308102132.0
006 m d
007 cr nn 008maaau
008 160715s2015 gw s 0 eng d
020 $a 9783319221892 $q (electronic bk.)
020 $a 9783319221885 $q (paper)
024 7 $a 10.1007/978-3-319-22189-2 $2 doi
035 $a 978-3-319-22189-2
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.C55
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.027 $2 23
090 $a R853.C55 $b P187 2015
245 0 0 $a Pan-cancer integrative molecular portrait towards a new paradigm in precision medicine $h [electronic resource] / $c edited by Christophe Le Tourneau, Maud Kamal.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a x, 144 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Introduction: Rationale for Precision Medicine Clinical Trials -- The Key Role of Pathology in the Context of Precision Medicine Trials -- Basis for Molecular Genetics in Cancer -- Microarrays Based Molecular Profiling to Identify Genomic Alterations -- High Throughput Technologies: DNA and RNA Sequencing Strategies and Potential -- Bioinformatics for Precision Medicine in Oncology -- Assessment of Biomarkers' Predictive Value of Efficacy -- Designs for Evaluating Precision Medicine Trials -- Conclusions and Perspectives: Challenges for the Clinical Implementation of Precision Medicine Trials.
520 $a This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the world's foremost cancer research institutions.
650 0 $a Clinical trials. $3 339385
650 0 $a Cancer $x Molecular aspects. $3 336981
650 0 $a Cancer $x Genetic aspects. $3 336980
650 1 4 $a Medicine& Public Health. $3 634332
650 2 4 $a Oncology. $3 205017
650 2 4 $a Pathology. $3 340546
650 2 4 $a Cancer Research. $3 463530
650 2 4 $a Molecular Medicine. $3 463625
700 1 $a Le Tourneau, Christophe. $3 634330
700 1 $a Kamal, Maud. $3 634331
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-22189-2
950 $a Medicine (Springer-11650)